Maquet Cardiopulmonary GmbH
USPTO PatentsView assignee record - 34 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Maquet ranks #9,316 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 11 technology areas.
- #9,316
- of 49,997 US assignees by volume
- 40th percentile
- by Innovation Score (32.2/100)
- 8.1
- avg claims per patent
- +29%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9316 · Foreign Corporation #9,316 · 34 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 34 grants
- UPPER-Q #9,316/49,997
- PHOTO-FINISH Magarl
- CPC-FOCUS A61M · 11 areas
- INNOV-THIN 32.2/100
- CLAIMS-PAR 8.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +29% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Magarl, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Maquet’s 32.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Maquet
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- American Orthodontics · near 32
American Orthodontics · near
32 score
- Ampio Pharmaceuticals · near 32
Ampio Pharmaceuticals · near
32 score
- Dyaco International · near 32
Dyaco International · near
32 score
- Ironburg Inventions · near 32
Ironburg Inventions · near
32 score
- Maquet Cardiopulmonary · this assignee 32
Maquet Cardiopulmonary · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Maquet's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Maquet?
Each dot is one of Maquet’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maquet’s own 8.1 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Maquet's grants concentrate
Maquet Cardiopulmonary GmbH is a focused PatentsView assignee: 11 CPC subclasses with 41.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2015. By volume, Maquet sits between MZ IP Holdings, LLC and Messer Industries USA, Inc..
Maquet's three-year grant acceleration
Maquet Cardiopulmonary GmbH shows 7 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Maquet's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- MZ IP Holdings
MZ IP Holdings, LLC
34 patents
- Magarl
Magarl, LLC
34 patents
- Mahindra and Mahi…
Mahindra and Mahindra Limited
34 patents
- Mainetti (UK)
Mainetti (UK) Ltd
34 patents
- Medtronic Ventor
Medtronic Ventor Technologies Ltd.
34 patents
- Mercury Plastics
Mercury Plastics LLC
34 patents
- Merrimack Pharmac…
Merrimack Pharmaceuticals, Inc.
34 patents
- Messer Industries…
Messer Industries USA, Inc.
34 patents
- Maquet Cardiopulm… ◀
Maquet Cardiopulmonary GmbH
34 patents
What this shows Maquet holds 34 patents at rank #9,323, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Maquet
By rank, the assignees closest to #9,323 in granted patent volume.
- MZ IP Holdings, LLC #9,319 · 34 patents
- Magarl, LLC #9,320 · 34 patents
- Mahindra and Mahindra Limited #9,321 · 34 patents
- Mainetti (UK) Ltd #9,322 · 34 patents
- Medtronic Ventor Technologies Ltd. #9,324 · 34 patents
- Mercury Plastics LLC #9,325 · 34 patents
- Merrimack Pharmaceuticals, Inc. #9,326 · 34 patents
- Messer Industries USA, Inc. #9,327 · 34 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Maquet's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Maquet, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Maquet ranks #503 of 3,490 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (32 here).
Maquet's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 40th percentile higher than 40% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 2.9% |
| 2016 | 6 | 17.6% |
| 2017 | 3 | 8.8% |
| 2018 | 1 | 2.9% |
| 2019 | 3 | 8.8% |
| 2020 | 6 | 17.6% |
| 2021 | 5 | 14.7% |
| 2022 | 1 | 2.9% |
| 2023 | 4 | 11.8% |
| 2024 | 2 | 5.9% |
| 2025partial year | 2 | 5.9% |
Which technologies does Maquet Cardiopulmonary GmbH patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Maquet Cardiopulmonary GmbH's patent record in context - here's where to go next.
- Maquet Cardiopulmonary GmbH's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 41.2% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #9,316 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Maquet Cardiopulmonary GmbH against MZ IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.